Psilocybin for Methamphetamine Use Disorder

计划入组 42 人 · 首次发布于 2026 年 8 月 19 日

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

计划入组 30 人 · 首次发布于 2021 年 7 月 29 日

Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder

计划入组 2 人 · 首次发布于 2022 年 9 月 28 日

biological therapeutic (substance use disorder)

MDMA-assisted therapy (alcohol use disorder)

Metamfetamine(Desoxyn)

C₁₀H₁₅N

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Clearmind Medicine

Vanda Pharmaceuticals

United States

Mirtazapine Shows Promise for Methamphetamine Use Disorder in Phase 3 Trial

UC San Diego Launches $12.3 Million Brain-FRAMe Program to Improve Brain Health in People with HIV and Methamphetamine Use Disorder

Myosin Therapeutics Secures $3M in Second Seed Funding to Advance Brain Cancer and Addiction Therapies